Serena Macrini

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 250 citations · Full text

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 111 citations

Advanced Cancer, Medicine, Immune Checkpoint Inhibitors +9

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

Olga Nigro, Graziella Pinotti, Federica De Galitiis et al. · European Journal of Cancer · 2020 · 61 citations

Cancer Immunosurveillance, Autoimmune Disease, Medicine +12

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience

Maurizio Valeriani, Luca Marinelli, Serena Macrini et al. · Radiation Oncology · 2019 · 23 citations · Full text

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Marco Russano, Alessio Cortellini, Raffaele Giusti et al. · Cancer Immunology Immunotherapy · 2021 · 21 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, Medicine +10